This compound is a pharmaceutical impurity reference standard, specifically a pyrazinoyl derivative of phenylalanine. It is characterized by the presence of both an amide and a carboxylic acid functional group, along with aromatic and heterocyclic ring systems.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1093959-75-1
N-[(2R)-2-Hydroxy-2-(3-hydroxyphenyl)ethyl]-N-methyl-glycine
Pharmaceutical intermediate for phenylephrine related compounds
N-Fmoc-N'-trityl-L-histidine
Protected amino acid for peptide synthesis
Tert-butyl (3R)-3-hydroxypyrrolidine-1-carboxylate
Pharmaceutical intermediate for API synthesis
Methyl 5-(chlorosulfonyl)-2-fluorobenzoate
Pharmaceutical intermediate
N-(Pyrazinylcarbonyl)-L-phenylalanine
Pharmaceutical intermediate
B-[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid
active pharmaceutical ingredient
Bortézomib
active pharmaceutical ingredient
5-methyl-N-[2-(4-sulfamoylphenyl)ethyl]pyrazine-2-carboxamide
pharmaceutical intermediate
3-phenyl-2-(pyrazine-2-carbonylamino)propanoic acid
DWYZPDHMMZGQAP-UHFFFAOYSA-N
C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C2=NC=CN=C2
—